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approach and was evaluated by an observer blinded to the MSCT
results.
Results: The diagnostic accuracy of MSCT for the detection or exclu-
sion of signiﬁcant stenosis in grafts body and their anastomotic sites
was 99.28%, sensitivity, speciﬁcity, positive and negative predictive
values were 97.75%, 100%, 100%, 98.95%. The diagnostic accuracy
for detection of degree of graft stenosis (mild, moderate, severe or
occluded) was 97.18%.
Conclusion: Noninvasive MSCT angiography is an excellent tool for
evaluating patency or degree of stenosis of bypass grafts body and
their anastomotic sites in post-CABG patients.
http://dx.doi.org/10.1016/j.ehj.2013.12.019
Diﬀerentiation between atrioventricular reentrant tachycardia (AVRT)
and AV nodal reentrant tachycardia (AVNRT)
Mohammad Shaﬁq a, Amir M. AbdelWahab b
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Diﬀerentiation between atrioventricular reentrant tachycardia
(AVRT) and AV nodal reentrant tachycardia (AVNRT) can be some-
times challenging in the EP lab. RV pacing during SVT produces pro-
gressive QRS fusion before QRS morphology becomes stable. This
fusion zone (FZ) may diﬀerentiate AVRT from AVNRT independent
of entrainment success. PPI-TCL during RV entrainment can help in
diﬀerentiation; however it has some fallacies and limitations. We
thought to compare the accuracy of atrial preexcitation (AP) & Stim-
ulus to atrial (S-A) interval ﬁxation in relation to fusion zone in iden-
tifying the mechanism of SVT.
We studied retrospectively and prospectively the eﬀect of properly
timed RVP on atrial timing during FZ. 118 SVT patients had RVP
within 40 ms shorter than tachycardia cycle length (TCL). S–A interval
and atrial CL were measured during FZ and with each QRS complex
thereafter. A ﬁxed S–A interval was deﬁned as variation <5 ms during
RVP & AP is the ﬁrst change in atrial CLP 10 ms.
9 patients were excluded due to cycle length oscillation > 10 ms
before the onset of RVP and 6 patients had atrial tachycardia (VA dis-
sociation with RVP) and were excluded. In the remaining 103 patients,
PPI-TCL was signiﬁcantly longer in AVNRT patients but postpacing
response couldn’t be assessed in 12 patients who showed consistent ter-
mination of tachycardia during RVP entrainments; 3 AVNRT patients
(5%) & 9 AVRT patients (22%). And when assessed it was not diag-
nostic in additional 4 (6%) patients with AVNRT (<115 ms) & 7
(17%) patients with ORT (P115 ms). Atrial pre-excitation (AP)
occurred during FZ in most AVRT patients and after FZ in most
AVNRT patients. However, S-A ﬁxation occurred during FZ in all
AVRT patients and after FZ in all AVNRT patients. Fixation of S-
A interval in relation to FZ was more accurate than either AP or
PPI-TCL in identifying the mechanism of SVT (100%, 92.4% and
84.8% consecutively).
We can conclude that during RVP within 40 ms of the tachycardia
cycle length, ﬁxed S–A interval and AP in relation to FZ were superior
to PPI-TCL measurement in identifying the mechanism of SVT.
http://dx.doi.org/10.1016/j.ehj.2013.12.020
Glycosylated hemoglobin (HBA1c) levels as follow-up for restenosis
clinical outcomes after coronary artery stenting in patients with diabetes
mellitus
Suzy Fawzi
Critical Care Department, Faculty of Medicine Cairo University,
Egypt.
Background: Diabetes has been shown to be independent predictor of
restenosis after percutaneous coronary intervention (PCI). Diabetes
mellitus has been proved to be a strong risk factor for in-stent resteno-
sis. Restenosis after stent implantation remains the “Achilles’heel” of
PCI, and patients with diabetes still have poorer clinical outcomes
compared to non-diabetics.1
Objective: (Aim of work) The aim of the present study is to evaluate
whether the level of HbA1c as an indicator for the glycaemic control
in diabetic patient is related to major cardiovascular events during
the follow up in diabetic patients after percutaneous coronary inter-
vention [(PCI) – stenting].
Methods: This study included 60 patients with diabetes 41 patient on
oral hypoglycemic agent and 19 patient on insulin at the time of the
study. These patients included 44 male (73.3%) and 16 female (26.7%)
with mean age 56.48 ± 7.8 years. All patients were subjected to stress
thallium at the end of follow-up period (24 month) or at the occurrence
of the cardiac events. Follow-upHbA1c were performed before stenting
and every 6 month till the end of follow-up period. In the study, 30 non-
diabetic patients, who underwent stenting, were enrolled as control.
Results: Regarding the duration of diabetes mellitus (in years),
patients who had cardiac events had longer duration of DM than
who did not (12.83 ± 6.8, 8.17 ± 3.3 yrs with p-value = 0.002).
LDL level was lower in the patients who had no cardiac events than
who did (108 ± 2.15 mg/dl, 123.67 ± 22.5 mg/dl with p-
value = 0.01). While patients who had cardiac events were on shorter
duration of clopidogrel than those who did not (9.7 ± 6.8 month,
16.4 ± 7.0 month with p-value 6 0.01).
Regarding the HbA1c levels, HbA1c in the patients with cardiac
events was P7% while in the none cardiac event patients was 67%
with p-value < 0.01. Also, HBA1c during stenting was higher than
HBA1c during follow-up in the whole diabetic group (9.12 ± 1.67%,
7.45 ± 2.0% with p-value <0.01.
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Conclusion:
– In diabetic patients undergoing coronary artery stenting, patients
with HbA1c levels 67% may have lower risk of restenosis and have
better clinical outcome after PCI at 2-year follow-up.
– Clopidogrel may reduce the risk of restenosis in diabetic patients
who underwent coronary artery stenting when used for more than
12 month or more (12–24 month).
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DNA content in children with congenital heart disease
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Background: CHD represents the most important component of pedi-
atric cardiovascular diseases. It has a high risk of morbidity and mor-
tality in newborns and infants. were considered as multifactorial
diseases. However genetic factors were considered as a corner stone
of their etiology. The DNA content represents the nuclear genomic
concentration. It is aﬀected by several multifactors.
Objective: The aim of our study was to determine the DNA content in
particular common congenital heart disease. To detect the correlation
between their DNA content and the chromosomal pattern as well as
with the hemodynamic aspect of CHD.
Material and methods: The present study was subjected on 30 children
suﬀering from the most common CHD and accordingly classiﬁed into
three groups; 1St (VSD) 2nd (TOF), 3’ (D-TGA), each included 10
cases with speciﬁc criteria and equally gender distribution, and ten
healthy age matched children as control group. All studied groups
were subjected to thorough clinical, functional, structural and hemody-
namic cardiac assessment as investigated via electrocardiogram, car-
diac X rays, full echocardiography, and cardiac catheterization
studies. Also full chromosomal, cytogenetic and DNA content studies
were applied.
Results: The value of structural and numerical chromosornal aberra-
tions was found to be signiﬁcantly higher in cyanotic congenital heart
disease (CCHD) than that of acyanotic congenital heart disease
(ACCHD). Current study revealed that there was a highly signiﬁcant
correlation between the incidence of the chromosomal aberrations
both structural and numerical as well as the aging and the mean values
of DNA content of CHD. Also there was highly signiﬁcant decreased
in DNA content values in CHD in comparison to control group and
the aﬀection in DNA content of (CCHD), was more aggressive than
in (ACCHD). However there was non signiﬁcant relation between
DNA content and the hemodynamic and function aspect of CHD.
Conclusion: DNA content of CHD was highly signiﬁcant reduced. It is
aﬀected by the incidence of chrornosomal aberrations, aging and the
cardiomyocytic apoptosis.
http://dx.doi.org/10.1016/j.ehj.2013.12.022
Drug eluting balloons in femoro-popliteal artery disease
Ahmed S. Gaweesh.
Background: Treatment of femoropopliteal artery disease by percuta-
neous transluminal angioplasty (PTA) is limited by high rates of reste-
nosis (40% to 60%) 6 to 12 months after procedure. The high
mechanical stress (bending, compression, torsion) that occurs in the
femoropopliteal arteries with normal patient movement is associated
with an increased risk for stent fractures and in-stent restenosis. Fur-
thermore, the reduction of restenosis seen with drug-eluting stent treat-
ment of coronary artery disease was not observed in several studies of
drug-eluting stent use in femoropopliteal artery disease. Hence, an
alternative stent-free therapy that may similarly reduce restenosis
and improve clinical outcome has been sought.
Objectives: To review the recent clinical trials using drug-eluting bal-
loons (DEB) in treatment of femoropopliteal artery disease.
Methods: There are four already ﬁnished randomized studies in
patients with superﬁcial femoral artery lesions investigating the eﬃcacy
of paclitaxel release by DEB. Currently there is a rapidly increasing
clinical study program using DEB in diﬀerent locations and
indications.
Results: All 4 trials demonstrated signiﬁcantly improved patency rates
at 12 and 24 months angiographic follow-up compared to standard
PTA. DEB oﬀer several advantages compared to drug eluting stents,
since any stentless technology for improving long-term patency is pref-
erable to overcome the drawbacks of stenting in this mobile segment.
Conclusions: DEB technology has demonstrated the capacity to have a
signiﬁcant impact on the practice of percutaneous cardiovascular inter-
ventions in the future. Several clinical trials have demonstrated prom-
ising early and mid-term results in treating femoropopliteal lesions.
Long-term results, exact indications, and optimal applications are
yet to be determined.
http://dx.doi.org/10.1016/j.ehj.2013.12.023
Early detection of left ventricular dysfunction in asymptomatic diabetic
patient using strain and strain rate echocardiographic imaging
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Background/aim: Diabetic cardiomyopathy is deﬁned as left ventricu-
lar dysfunction that occurs independently of coronary artery disease,
and hypertension. The aim of this study is to investigate early altera-
tions in left ventricular systolic and diastolic functions in patients with
type 2 diabetes mellitus using strain and strain rate Echo compared
with normal subjects.
Patients and methods: he present study enrolled forty subjects. They
were divided into two groups: Group (1): Patients with only type 2 dia-
betes mellitus (20 Patients).Group (2) Normal Subjects as controls (20
Patients).All patients of type 2 diabetes mellitus according to the WHO
criteria treated with oral hypo glycemic drugs. Mean age of diabetic
group is (53.05  7.02). All the studied groups were subjected to: full
history taking and clinical examination, resting 12 leads surface elec-
tro-cardiogram, laboratory assessment of Glycosylated Hb, standard
trans-thoracic echocardiography, tissue Doppler imaging, strain and
strain rate imaging.
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